Nifty
Sensex
:
:
25030.35
81028.02
493.75 (2.01%)
1718.01 (2.17%)

Pharmaceuticals & Drugs - Global

Rating :
57/99

BSE: 506690 | NSE: UNICHEMLAB

501.70
06-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  485.55
  •  513
  •  485
  •  493.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  84039
  •  42277174.45
  •  687.2
  •  278.2

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,541.06
  • 10.45
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,855.25
  • N/A
  • 1.27

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.22%
  • 0.33%
  • 14.90%
  • FII
  • DII
  • Others
  • 2.7%
  • 8.87%
  • 2.98%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.18
  • 11.64
  • 7.24

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 20.40
  • 16.21

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 50.21
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 9.24

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.03
  • 1.28
  • 1.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.14
  • 19.18
  • 24.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
640.22
578.96
10.58%
632.62
526.60
20.13%
575.12
587.18
-2.05%
521.17
533.09
-2.24%
Expenses
565.76
512.78
10.33%
562.68
504.11
11.62%
527.44
503.48
4.76%
476.39
447.57
6.44%
EBITDA
74.46
66.18
12.51%
69.94
22.49
210.98%
47.68
83.70
-43.03%
44.78
85.52
-47.64%
EBIDTM
11.63%
11.43%
11.06%
4.27%
8.29%
14.25%
8.59%
16.04%
Other Income
15.37
20.97
-26.70%
15.61
6.82
128.89%
23.47
9.25
153.73%
11.80
13.62
-13.36%
Interest
7.71
8.24
-6.43%
6.62
6.54
1.22%
9.39
5.46
71.98%
7.42
6.75
9.93%
Depreciation
30.49
31.47
-3.11%
29.94
31.79
-5.82%
30.61
29.69
3.10%
31.25
30.54
2.32%
PBT
27.37
-10.82
-
48.99
-9.02
-
18.79
57.80
-67.49%
293.43
61.85
374.42%
Tax
5.15
1.07
381.31%
7.52
1.45
418.62%
7.88
4.83
63.15%
29.14
4.00
628.50%
PAT
22.22
-11.89
-
41.47
-10.47
-
10.91
52.97
-79.40%
264.29
57.85
356.85%
PATM
3.47%
-2.05%
6.56%
-1.99%
1.90%
9.02%
50.71%
10.85%
EPS
3.16
-1.69
-
5.89
-1.49
-
1.55
7.52
-79.39%
37.54
8.22
356.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
2,369.13
2,201.85
2,110.97
1,785.11
1,343.02
1,269.83
1,235.14
1,103.71
1,180.05
814.59
697.71
Net Sales Growth
6.44%
4.31%
18.25%
32.92%
5.76%
2.81%
11.91%
-6.47%
44.86%
16.75%
 
Cost Of Goods Sold
1,064.20
933.61
751.11
637.70
482.45
356.91
302.14
308.63
364.19
274.97
188.77
Gross Profit
1,304.93
1,268.24
1,359.86
1,147.41
860.57
912.92
933.00
795.08
815.85
539.62
508.94
GP Margin
55.08%
57.60%
64.42%
64.28%
64.08%
71.89%
75.54%
72.04%
69.14%
66.24%
72.94%
Total Expenditure
2,132.27
2,017.68
1,846.11
1,698.23
1,388.58
1,197.04
1,144.03
1,154.53
1,263.54
946.48
739.11
Power & Fuel Cost
-
106.26
108.16
107.14
102.84
78.05
68.89
73.02
76.39
49.23
41.62
% Of Sales
-
4.83%
5.12%
6.00%
7.66%
6.15%
5.58%
6.62%
6.47%
6.04%
5.97%
Employee Cost
-
396.63
402.21
403.20
356.41
330.49
306.97
273.28
238.52
200.64
169.04
% Of Sales
-
18.01%
19.05%
22.59%
26.54%
26.03%
24.85%
24.76%
20.21%
24.63%
24.23%
Manufacturing Exp.
-
189.69
242.87
227.83
194.60
193.21
215.73
232.08
242.23
125.30
103.70
% Of Sales
-
8.62%
11.51%
12.76%
14.49%
15.22%
17.47%
21.03%
20.53%
15.38%
14.86%
General & Admin Exp.
-
211.73
139.75
138.44
119.02
109.60
123.98
147.90
128.70
182.80
126.15
% Of Sales
-
9.62%
6.62%
7.76%
8.86%
8.63%
10.04%
13.40%
10.91%
22.44%
18.08%
Selling & Distn. Exp.
-
175.24
202.01
183.92
129.56
120.68
122.52
116.12
197.24
108.38
107.77
% Of Sales
-
7.96%
9.57%
10.30%
9.65%
9.50%
9.92%
10.52%
16.71%
13.30%
15.45%
Miscellaneous Exp.
-
4.52
0.00
0.00
3.70
8.11
3.81
3.50
16.26
5.16
107.77
% Of Sales
-
0.21%
0%
0%
0.28%
0.64%
0.31%
0.32%
1.38%
0.63%
0.30%
EBITDA
236.86
184.17
264.86
86.88
-45.56
72.79
91.11
-50.82
-83.49
-131.89
-41.40
EBITDA Margin
10.00%
8.36%
12.55%
4.87%
-3.39%
5.73%
7.38%
-4.60%
-7.08%
-16.19%
-5.93%
Other Income
66.25
63.06
35.32
31.59
38.52
47.51
50.19
91.31
98.41
60.88
5.50
Interest
31.14
31.59
21.03
22.66
17.31
6.11
5.12
7.85
7.52
8.01
3.36
Depreciation
122.29
125.12
124.56
123.16
113.44
91.17
84.36
81.67
67.37
50.51
43.52
PBT
388.58
90.52
154.59
-27.35
-137.80
23.03
51.82
-49.02
-59.97
-129.53
-82.76
Tax
49.69
39.54
17.07
8.80
25.86
-11.09
17.15
11.97
-34.35
3.34
-11.85
Tax Rate
12.79%
13.52%
11.04%
-10.36%
-14.66%
-48.15%
33.10%
-24.42%
57.28%
-2.58%
14.32%
PAT
338.89
252.84
137.52
-93.76
-202.23
33.06
34.32
-60.18
-25.56
-133.10
-70.72
PAT before Minority Interest
338.89
252.84
137.52
-93.76
-202.23
33.06
34.32
-60.18
-25.56
-133.10
-70.72
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
14.30%
11.48%
6.51%
-5.25%
-15.06%
2.60%
2.78%
-5.45%
-2.17%
-16.34%
-10.14%
PAT Growth
283.10%
83.86%
-
-
-
-3.67%
-
-
-
-
 
EPS
48.14
35.91
19.53
-13.32
-28.73
4.70
4.88
-8.55
-3.63
-18.91
-10.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
2,717.44
2,450.59
2,438.30
2,435.30
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
Share Capital
14.08
14.08
14.08
14.08
14.08
14.08
14.08
14.08
14.07
18.18
Total Reserves
2,697.43
2,431.39
2,421.16
2,409.18
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
Non-Current Liabilities
103.50
98.72
92.27
108.03
143.88
49.16
43.72
10.10
46.46
64.49
Secured Loans
39.12
60.81
38.22
63.65
89.01
0.00
0.00
0.00
0.33
0.44
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
28.64
37.86
35.80
41.91
39.96
30.41
23.51
14.60
10.76
25.33
Current Liabilities
885.94
991.97
737.60
639.60
552.13
505.76
566.73
502.92
463.51
392.62
Trade Payables
356.63
386.94
351.26
290.69
183.19
210.08
250.22
221.41
226.23
210.73
Other Current Liabilities
109.17
122.76
93.01
128.34
135.06
176.97
122.04
68.45
63.03
68.01
Short Term Borrowings
415.44
340.29
155.27
208.08
215.69
100.63
184.03
199.67
150.29
97.62
Short Term Provisions
4.70
141.98
138.06
12.50
18.19
18.09
10.44
13.39
23.97
16.25
Total Liabilities
3,706.88
3,541.28
3,268.17
3,182.93
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
Net Block
1,212.58
1,299.57
1,252.40
1,256.66
990.03
880.42
866.06
806.29
574.45
487.22
Gross Block
1,991.76
1,993.53
1,919.54
1,750.29
1,379.74
1,193.56
1,098.27
975.96
689.74
561.37
Accumulated Depreciation
779.18
693.96
667.14
493.63
389.70
313.14
232.21
169.67
115.29
74.15
Non Current Assets
1,506.29
1,505.67
1,521.50
1,591.06
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
Capital Work in Progress
100.14
30.67
122.71
147.45
493.81
567.50
330.47
92.39
238.15
249.98
Non Current Investment
0.02
0.02
0.02
0.16
0.28
155.59
130.78
125.54
5.48
5.72
Long Term Loans & Adv.
193.55
150.61
124.92
168.07
165.59
112.89
112.90
56.37
24.05
20.40
Other Non Current Assets
0.00
24.80
21.45
18.72
16.30
14.52
11.52
9.39
7.74
5.17
Current Assets
2,197.34
2,029.47
1,743.32
1,588.47
1,644.92
1,377.32
1,686.47
2,038.41
2,336.47
748.46
Current Investments
0.00
0.00
1.34
1.54
263.58
236.43
419.10
800.75
895.55
8.00
Inventories
974.97
988.74
736.26
625.23
600.22
538.34
396.54
338.66
272.86
281.71
Sundry Debtors
828.58
778.81
642.31
588.62
495.43
250.27
390.14
436.05
276.92
315.32
Cash & Bank
294.70
117.63
158.16
185.36
114.10
82.45
233.81
200.99
681.46
16.14
Other Current Assets
99.09
42.71
29.79
31.31
171.59
269.83
246.88
261.96
209.67
127.29
Short Term Loans & Adv.
66.43
101.58
175.46
156.40
138.12
213.83
188.87
200.78
148.85
100.72
Net Current Assets
1,311.40
1,037.50
1,005.72
948.86
1,092.80
871.56
1,119.74
1,535.50
1,872.95
355.84
Total Assets
3,703.63
3,535.14
3,264.82
3,179.53
3,310.94
3,111.76
3,141.80
3,132.05
3,190.06
1,520.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
3.64
-7.02
14.00
-85.09
-259.61
32.98
19.82
-327.77
-112.34
68.19
PBT
292.38
154.59
-84.96
-176.36
21.97
51.48
-48.21
-57.44
3,241.14
141.25
Adjustment
-73.04
148.70
197.32
132.84
80.46
65.65
18.79
6.80
-3,207.66
53.31
Changes in Working Capital
-208.13
-293.89
-91.99
-29.36
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
Cash after chg. in Working capital
11.21
9.40
20.37
-72.88
-252.00
47.35
24.15
-315.57
-113.20
95.91
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.57
-16.42
-6.37
-12.21
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
192.06
-241.23
50.40
202.81
102.40
-73.56
-35.91
-286.01
1,648.33
-127.87
Net Fixed Assets
-94.95
-115.91
-1.93
-20.93
-121.73
-327.70
-338.73
-139.02
-107.71
-135.60
Net Investments
-1.87
-1.54
-3.56
349.28
130.62
147.85
374.18
-63.65
-889.43
21.19
Others
288.88
-123.78
55.89
-125.54
93.51
106.29
-71.36
-83.34
2,645.47
-13.46
Cash from Financing Activity
1.86
183.76
-106.31
-81.30
191.23
-121.07
-62.30
-2.42
-881.13
59.23
Net Cash Inflow / Outflow
197.56
-64.49
-41.91
36.42
34.01
-161.65
-78.40
-616.19
654.86
-0.46
Opening Cash & Equivalents
89.58
154.75
183.75
109.20
77.46
231.52
197.05
666.07
11.21
11.67
Closing Cash & Equivalent
289.48
89.58
154.75
183.75
109.20
77.46
231.52
197.05
666.07
11.21

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
385.16
347.37
345.91
344.18
370.38
362.05
358.85
371.69
380.95
116.88
ROA
6.97%
4.04%
-2.91%
-6.22%
1.03%
1.11%
-1.94%
-0.75%
108.06%
7.68%
ROE
9.81%
5.64%
-3.86%
-8.04%
1.28%
1.37%
-2.37%
-0.90%
136.04%
10.77%
ROCE
10.68%
6.34%
-2.31%
-5.60%
1.00%
2.12%
-1.49%
-1.77%
162.77%
13.42%
Fixed Asset Turnover
1.10
1.08
0.97
0.86
0.99
1.08
1.06
1.43
2.21
3.08
Receivable days
133.23
122.86
125.84
147.31
107.17
94.63
136.61
109.51
78.30
63.41
Inventory Days
162.76
149.13
139.19
166.52
163.63
138.14
121.57
93.93
73.33
60.67
Payable days
145.35
179.36
183.72
179.25
201.09
278.03
76.39
73.41
94.97
104.25
Cash Conversion Cycle
150.64
92.63
81.32
134.58
69.71
-45.27
181.78
130.03
56.65
19.82
Total Debt/Equity
0.17
0.18
0.09
0.12
0.13
0.04
0.07
0.08
0.06
0.09
Interest Cover
10.26
8.35
-2.75
-9.19
4.60
11.12
-5.25
-6.64
405.79
43.00

News Update:


  • Unichem Laboratories - Quarterly Results
    5th Nov 2026, 00:00 AM

    Read More
  • USFDA concludes inspection at Unichem Laboratories’ Goa Formulation facility
    28th Sep 2026, 09:21 AM

    The inspection was conducted from September 21, 2026 to September 26, 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.